Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (6 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
2 selected
)
Type
Guidance (219)
Quality standard (0)
Guidance programme
(
3 selected
)
Guidance programme
Antimicrobial prescribing guidelines (2)
Clinical guidelines (45)
Diagnostics guidance (6)
Health technology evaluations (3)
Highly specialised technologies guidance (8)
Interventional procedures guidance (63)
Medical technologies guidance (27)
NICE guidelines (57)
Public health guidelines (7)
Social care guidelines (9)
Technology appraisal guidance (186)
Apply filters
Showing 11 to 20 of 219
Sort by
Date
Title
Apply sorting
Last updated date between 1/4/2021 and 31/3/2023
Remove Last updated date between 1/4/2021 and 31/3/2023 filter
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Medical technologies guidance
Remove Guidance programme: Medical technologies guidance filter
Guidance programme: Diagnostics guidance
Remove Guidance programme: Diagnostics guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Nivolumab with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma
TA865
8 February 2023
8 February 2023
Regorafenib for previously treated metastatic colorectal cancer
TA866
8 February 2023
8 February 2023
Upadacitinib for treating active non-radiographic axial spondyloarthritis
TA861
1 February 2023
1 February 2023
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments
TA862
1 February 2023
1 February 2023
Somatrogon for treating growth disturbance in children and young people aged 3 years and over
TA863
1 February 2023
1 February 2023
Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted
TA864
1 February 2023
1 February 2023
Maribavir for treating refractory cytomegalovirus infection after transplant
TA860
18 January 2023
18 January 2023
Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (terminated appraisal)
TA859
16 January 2023
16 January 2023
MRI-based technologies for assessing non-alcoholic fatty liver disease
DG50
12 January 2023
12 January 2023
Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma
TA857
11 January 2023
11 January 2023
Previous page
1
Current page
2
3
4
…
22
Page
2
of
22
Next page
Results per page
10
25
50
All
Back to top